Baseline Hypothetical Facility for the Production of 131 I, 99 Mo, and 133 Xe from HALEU Fission Targets
The report describes the development of a hypothetical facility to produce the pharmaceutical radioisotope 131 I at an amount of 60 curies per week via the fission of a High Assay Low Enriched Uranium (HALEU) target, along with the chemical and physical processes and equipment needed to separate the 131 I and co-produced 99 Mo and 133 Xe. The hypothetical design was carried out using a 10 MWt research reactor. The irradiation calculation determined that three HALEU targets with aluminum cladding can be used to produce 60 Ci/week of 131 I, 750 Ci/week of 99 Mo and 560 Ci/week of 133 Xe. The process selected for the baseline design uses caustic dissolution of the target material with ion exchange processes to separate and purify the iodine and molybdenum. The xenon is processed using a cryogenic carbon bed separation process. Target processing occurs in seven shielded hot cells with a total footprint of 16m 2 and waste management occurs in an eight hot cell with a 2.5 m 2 footprint. Waste generated from the processing of the three targets per week would generate less than 4 shielded drums of waste annually. These hot cells would need varying levels of shielding due to the amount of fission products being handled in the unit. Hot cell facilities also require support services including QA/QC, health physics, administrative staff, operator changing room, radiological buffer areas, and waste storage. The overall facility would require a footprint of 1050 m 2 with 20.25 m 2 of shielded hot cells.